E. Hong

High management impact of Ga‐68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours

R. Hicks, M. Hofman, O. Neels, 2012, Journal of medical imaging and radiation oncology.

64Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry for Peptide Receptor Radionuclide Therapy

R. Hicks, M. Hofman, T. Akhurst, 2018, The Journal of Nuclear Medicine.

First-in-human trial of 64 Cu-SARTATE PET imaging of patients with neuroendocrine tumours demonstrates high tumor uptake and retention, potentially allowing prospective dosimetry for peptide receptor radionuclide therapy

R. Hicks, M. Hofman, T. Akhurst, 2018 .

How do oncologists deal with incidental abnormalities on whole‐body fluorine‐18 fluorodeoxyglucose PET/CT?

D. Binns, A. Hogg, R. Hicks, 2007, Cancer.

Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study of 68Ga-Tris(Hydroxypyridinone)-PSMA PET/CT in Patients with Prostate Cancer

D. Murphy, S. Siva, R. Hicks, 2017, The Journal of Nuclear Medicine.

ANZSNM - 46th Annual Scientific Meeting, Rotorua, 22-25 April 2016 - 'Hot Science: An Eruption of Isotopes.'.

V. Bray, S. Fourlanos, D. Forstner, 2016, Internal medicine journal.